Medtronic Ventures focuses its investments on early-stage to late-stage growth companies in medical technology, patient care solutions, advanced therapeutic devices, diagnostics, and pharmaceuticals globally. The firm's strategy prioritizes strategic development companies with the potential for future acquisition by Medtronic, aiming to foster innovation and make sound financial investments.
100% of their portfolio is in Healthcare. Their most common stage is series-c (100% of deals).
Portfolio
1
Fund Size
—
Top Stage
Series C
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Portfolio
1 investment
| Company | Round | Amount | Date |
|---|---|---|---|
 Earlens Corporation, Inc. | Series C | $73M | Jun 2017 |
Top Co-Investors
NEA (New Enterprise Associates)1 shared
CRG1 shared
Windham Venture Partners1 shared
SightLine Partners1 shared
Lightstone Ventures1 shared
Last updated: 4 May 2026